Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOCICLIB Cause Product availability issue? 109 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Product availability issue have been filed in association with RIBOCICLIB (KISQALI). This represents 0.4% of all adverse event reports for RIBOCICLIB.

109
Reports of Product availability issue with RIBOCICLIB
0.4%
of all RIBOCICLIB reports
8
Deaths
35
Hospitalizations

How Dangerous Is Product availability issue From RIBOCICLIB?

Of the 109 reports, 8 (7.3%) resulted in death, 35 (32.1%) required hospitalization, and 9 (8.3%) were considered life-threatening.

Is Product availability issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 109 reports have been filed with the FAERS database.

What Other Side Effects Does RIBOCICLIB Cause?

Neutropenia (3,585) Nausea (3,404) Fatigue (3,327) Malignant neoplasm progression (2,468) Death (2,452) Vomiting (1,953) Diarrhoea (1,830) White blood cell count decreased (1,683) Pain (1,637) Metastases to bone (1,538)

What Other Drugs Cause Product availability issue?

RUXOLITINIB (2,142) LISDEXAMFETAMINE DIMESYLATE (1,530) CERTOLIZUMAB PEGOL (1,381) VEDOLIZUMAB (636) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610) METHYLPHENIDATE (444) SECUKINUMAB (399) BIMEKIZUMAB-BKZX (364) LACOSAMIDE (359) BRIVARACETAM (324)

Which RIBOCICLIB Alternatives Have Lower Product availability issue Risk?

RIBOCICLIB vs RIBOFLAVIN RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE RIBOCICLIB vs RIFABUTIN RIBOCICLIB vs RIFAMPICIN

Related Pages

RIBOCICLIB Full Profile All Product availability issue Reports All Drugs Causing Product availability issue RIBOCICLIB Demographics